Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Gene Therapy for Artemis-SCID and Artemis-Leaky-SCID Patients: Preliminary Results of the French Artegene Phase I/II Clinical Trial

Blood (2024) 144 (Supplement 1): 2201.

https://doi.org/10.1182/blood-2024-208350

Published: 2024

Journal Articles

Inherited human Apollo deficiency causes severe bone marrow failure and developmental defects

Blood (2022) 139 (16): 2427–2440.

https://doi.org/10.1182/blood.2021010791

Published: 2022

Includes: Supplemental data

Journal Articles

EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

Blood (2019) 134 (3): 277–290.

https://doi.org/10.1182/blood.2018893404

Published: 2019

Includes: Supplemental data

Journal Articles

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID

Blood (2014) 123 (2): 281–289.

https://doi.org/10.1182/blood-2013-01-476432

Published: 2014

Includes: Supplemental data

Journal Articles

Correction of Artemis Deficiency In Murine Hematopoietic Stem Cell by I-Sce 1 Meganuclease and Artemis Recombination Matrix Mediated Homologous Recombination.

Julie Rivière, Julia Hauer, MD, Laurent Poirot, Julien Brochet, Frédéric Pâques, Jean-Pierre De-Villartay, Alain Fischer, Marina Cavazzana-Calvo, MD, PhD

Blood (2010) 116 (21): 3770.

https://doi.org/10.1182/blood.V116.21.3770.3770

Published: 2010

Journal Articles

Reduced immunoglobulin class switch recombination in the absence of Artemis

Paola Rivera-Munoz, Pauline Soulas-Sprauel, Gwenaël Le Guyader, Vincent Abramowski, Sylvia Bruneau, Alain Fischer, Frédéric Pâques, Jean-Pierre de Villartay

Blood (2009) 114 (17): 3601–3609.

https://doi.org/10.1182/blood-2008-11-188383

Published: 2009

Journal Articles

Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency

Bénédicte Neven, Sandrine Leroy, Hélène Decaluwe, Francoise Le Deist, Capucine Picard, Despina Moshous, Nizar Mahlaoui, Marianne Debré, Jean-Laurent Casanova, Liliane Dal Cortivo, Yoann Madec, Salima Hacein-Bey-Abina, Geneviève de Saint Basile, Jean-Pierre de Villartay, Stéphane Blanche, Marina Cavazzana-Calvo, Alain Fischer

Blood (2009) 113 (17): 4114–4124.

https://doi.org/10.1182/blood-2008-09-177923

Published: 2009

Includes: Supplemental data

Journal Articles

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders

Isabelle Plo, Mayuka Nakatake, Laurent Malivert, Jean-Pierre de Villartay, Stéphane Giraudier, Jean-Luc Villeval, Lisa Wiesmuller, William Vainchenker

Blood (2008) 112 (4): 1402–1412.

https://doi.org/10.1182/blood-2008-01-134114

Published: 2008

Journal Articles

Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity

Chantal Lagresle-Peyrou, Frank Yates, Michèle Malassis-Séris, Christophe Hue, Estelle Morillon, Alexandrine Garrigue, Allen Liu, Philippe Hajdari, Daniel Stockholm, Olivier Danos, Brigitte Lemercier, Marie-Lise Gougeon, Frederic Rieux-Laucat, Jean-Pierre de Villartay, Alain Fischer, Marina Cavazzana-Calvo

Blood (2006) 107 (1): 63–72.

https://doi.org/10.1182/blood-2005-05-2032

Published: 2006

Includes: Supplemental data

Journal Articles

Retroviral Gene Therapy of RAG-1-/- Mice: Balance between Efficiency and Toxicity.

Chantal Lagresle-Peyrou, PhD, Frank Yates, PhD, Michele Malassis-Seris, Christophe Hue, Estelle Morillon, Alexandrine Garrigue, Allen Liu, MD, Philippe Hajdari, Daniel Stockholm, PhD, Olivier Danos, PhD, Brigitte Lemercier, Marie-Lize Gougeon, PhD, Frederic Rieux-laucat, PhD, Jean-Pierre de Villartay, PhD, Alain Fischer, PU, PH, Marina Cavazzana-Calvo, PU, PH

Blood (2005) 106 (11): 460.

https://doi.org/10.1182/blood.V106.11.460.460

Published: 2005

Journal Articles

Omenn syndrome: more than a disorder of RAG1 or RAG2 genes

Marina Cavazzana-Calvo, Jean-Pierre de Villartay

Blood (2005) 105 (11): 4156.

https://doi.org/10.1182/blood-2005-03-1166

Published: 2005

Journal Articles

Restoration of B Cell Development after Lentiviral Transduction of CD34+ Hematopoietic Cells from RAG-1 Deficient Patient.

Chantal Lagresle-Peyrou, PhD, Pierre Charneau, PhD, Christophe Hue, Karine Mollier, Isabelle Andre-Schmutz, PhD, Delphine Bonhomme, Salima Hacein-Bey-Abina, harmaD, PhD, Jean-Pierre de Villartay, PhD, Alain Fischer, MD, PhD, Marina Cavazzana-Calvo, MD, PhD

Blood (2004) 104 (11): 5246.

https://doi.org/10.1182/blood.V104.11.5246.5246

Published: 2004

Journal Articles

Gene therapy of RAG-2−/− mice: sustained correction of the immunodeficiency

Frank Yates, Michèle Malassis-Séris, Daniel Stockholm, Cécile Bouneaud, Frédérique Larousserie, Patricia Noguiez-Hellin, Olivier Danos, Donald B. Kohn, Alain Fischer, Jean-Pierre de Villartay, Marina Cavazzana-Calvo

Blood (2002) 100 (12): 3942–3949.

https://doi.org/10.1182/blood-2002-03-0782

Published: 2002

Journal Articles

Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B–severe combined immune deficiency or Omenn syndrome

Barbara Corneo, Despina Moshous, Tayfun Güngör, Nicolas Wulffraat, Pierre Philippet, Françoise Le Deist, Alain Fischer, Jean-Pierre de Villartay

Blood (2001) 97 (9): 2772–2776.

https://doi.org/10.1182/blood.V97.9.2772

Published: 2001

Journal Articles

Lymphoproliferative Syndrome With Autoimmunity: A Possible Genetic Basis for Dominant Expression of the Clinical Manifestations

Frédéric Rieux-Laucat, Séverine Blachère, Sylvia Danielan, Jean Pierre De Villartay, Mathias Oleastro, Eric Solary, Brigitte Bader-Meunier, Peter Arkwright, Corinne Pondaré, Françoise Bernaudin, Helen Chapel, Susan Nielsen, Mohamed Berrah, Alain Fischer, Françoise Le Deist

Blood (1999) 94 (8): 2575–2582.

https://doi.org/10.1182/blood.V94.8.2575.420k17_2575_2582

Published: 1999

NARROW

Gene Therapy for Artemis-SCID and Artemis-Leaky-SCID Patients: Preliminary Results of the French Artegene Phase I/II Clinical Trial

Inherited human Apollo deficiency causes severe bone marrow failure and developmental defects

EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID

Correction of Artemis Deficiency In Murine Hematopoietic Stem Cell by I-Sce 1 Meganuclease and Artemis Recombination Matrix Mediated Homologous Recombination.

Reduced immunoglobulin class switch recombination in the absence of Artemis

Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders

Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity

Retroviral Gene Therapy of RAG-1-/- Mice: Balance between Efficiency and Toxicity.

Omenn syndrome: more than a disorder of RAG1 or RAG2 genes

Restoration of B Cell Development after Lentiviral Transduction of CD34+ Hematopoietic Cells from RAG-1 Deficient Patient.

Gene therapy of RAG-2−/− mice: sustained correction of the immunodeficiency

Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B–severe combined immune deficiency or Omenn syndrome

Lymphoproliferative Syndrome With Autoimmunity: A Possible Genetic Basis for Dominant Expression of the Clinical Manifestations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only